Lawmakers Slam Private Equity ‘Octopus’ for Health-Care Strategy

  • More transparency needed on ownership and financial data
  • Industry’s investment in nursing homes becomes focus
Photographer: Maskot/Getty Images
Lock
This article is for subscribers only.

Private equity’s control of health-care companies requires greater scrutiny to better assess the impact on the industry, several U.S. lawmakers said Thursday.

Independent industry experts fielded questions from lawmakers at a House Ways and Means subcommittee hearing about private equity’s growing influence and recommended requiring health-care companies to disclose more financial and ownership data.